CTRI/2011/06/001813已完成4 期
Assessment of Efficacy, Safety and Tolerability of Hair4U 10% (minoxidil 10% plus Aminexil 1.5%) in the treatment of Androgenetic Alopecia
Glenmark Pharmaceuticals Ltd0 个研究点目标入组 75 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 75
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Pms
入排标准
入选标准
- •Subjects with androgenetic alopecia grade from II to IV.
- •Male subjects must be between 18-50years of age.
- •Subject must provide informed consent and comply with protocol.
排除标准
- •Subjects not willing to discontinue all the treatments of androgenetic alopecia 2 weeks prior to enrollement in the study.
- •hypersensitivity o any of the ingredients.
- •subjects taking concomitant therapy that might interfere with the study results in investigators opinion.
- •subjects with dermatological disorder of scalp that miht interfere with study evaluation.
研究者
相似试验
已完成
4 期
A Clinical trial to study the effects and tolerability of Dacne gel containing Clindamycin Phosphate 1% and zinc acetate in patients suffering from acne.CTRI/2011/091/000041Glenmark Pharmaceuticals Ltd125
已完成
4 期
Assessment of Efficacy, Safety and Tolerability of Fixed Dose Combination Wunder Eye Cream (3% Biophytex LS 8740 an 5% Proteasyl TP LS 8657) in the treatment of under Eye Dark Circles.CTRI/2011/04/001672Glenmark Pharmaceuticals Limited20
已完成
不适用
Observational Study on cough syrupCTRI/2015/09/006198Dr Reddys laboratories Ltd250
已完成
4 期
Study of Efficacy, Safety and Tolerability of Na-Picosulphate in patients requiring anorectal surgeryCTRI/2016/09/007292VYAS SURGERY100
招募中
4 期
Assessment of Steroneo Skin Cream (Physalis Angulata Supercritical Extract) application for treatment of eczematous lesionsCTRI/2016/11/007511Rehmat Clinic50